Home
Conditions
Fallopian Tube Diseases

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Not Yet Recruiting

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

NCT07495124

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China

NCT07604766

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: Beijing Cancer Hospital Beijing, China

Peking Union Medical College Hospital Beijing, China

Chongqing University Cancer Hospital - Chongqing Cancer Hospital Chongqing, China

Fujian Provincial Cancer Hospital Fujian, China

View all 20 locations

View Trial Details

Not Yet Recruiting

IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer

NCT07674615

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations: Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

NCT07545460

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Yunnan Cancer Hospital Kunming, Yunnan, China

View Trial Details

Not Yet Recruiting

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

NCT07591831

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

NCT07265739

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer

NCT07489300

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer

NCT07432594

Conditions: Adnexal Diseases, Fallopian Tube Cancers, Fallopian Tube Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

NCT07362147

Conditions: Adnexal Diseases, Cervical Cancer, Endocrine Gland Neoplasms, +30 more
Locations: Taipei Veterans General Hospital Taipei, No.201, Sec. 2, Shipai Rd., Beitou District, Taiwan

View Trial Details

Not Yet Recruiting

Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance

NCT07269574

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: Not specified

View Trial Details

Fallopian Tube Diseases

Fallopian Tube Diseases trial results

Related conditions